Denali Therapeutics, Inc. (DNLI)
18.95
+0.84
(+4.64%)
USD |
NASDAQ |
May 20, 13:02
Denali Therapeutics Total Liabilities (Quarterly) : 339.92M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 10.83B |
| Neurocrine Biosciences, Inc. | 1.499B |
| Arcturus Therapeutics Holdings, Inc. | 54.05M |
| Agenus, Inc. | 414.44M |
| Curis, Inc. | 16.98M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.266B |
| Shareholders Equity (Quarterly) | 926.10M |
| Debt to Equity Ratio | 0.0432 |
| Current Ratio | 9.285 |
| Net Debt Paydown Yield | 0.09% |